NEWS & EVENTS
illustration of a heart

American Heart Association Scientific Sessions 2021

November 13 - 15, 2021
Virtual

Description

The National Institutes of Health National Heart, Lung, and Blood Institute (NHLBI) will be participating in the 2021 American Heart Association (AHA) Virtual Scientific Sessions from November 13 – 15, 2021. NHLBI research and NHLBI-funded research will be presented at more than 30 sessions. See the schedule below for a snapshot of NHLBI’s sessions at AHA 2021.Visit AHA’s website and program planner for a full schedule and updates.

Please note: schedule is subject to change.


Saturday, November 13, 2021


Live Sessions

Session CH.AOS.463
226 - Impact of Norwood shunt type on cardiac function and clinical outcomes in survivors to early adolescence with hypoplastic left heart syndrome and other single right ventricular anomalies: A report from the single ventricle reconstruction (SVR) III study
Caren Goldberg, M.D.
8:12 – 8:24 a.m. ET

LATE-BREAKING Session LBS.01
226 Evaluating the benefit of concomitant tricuspid repair during mitral valve surgery
Annetine C. Gelijns, Ph.D., Marissa Miller, D.V.M., Wendy Taddei-Peters, Ph.D., Neal Jeffries, Ph.D.
9:43 – 9:53 a.m. ET

LATE-BREAKING Session LBS.01
Efficacy and safety of an external support device for saphenous vein coronary bypass grafts: The VEST trial
10:11 – 10:19 a.m. ET

Session CS.ME.1188
Cardiovascular health after 10 years: What have we learned and what is the future?
Moderator: David Goff, M.D., Ph.D.
11:00 a.m. – 12:15 p.m. ET

Session LS.08
National Heart, Lung, and Blood Institute Small Business Grant Program: Live Virtual Pitch Event
Recovery Force, Optima Integrated Health, Cornovus Pharmaceuticals, Elucid Bio, Exhalix, 3DT Holdings
3:00  – 4:30 p.m. ET

Session FS.02
Whole-heart quantification and characterization of coronary atherosclerotic burden and risk of major adverse cardiovascular events: The Ischemia Trial
James Min, M.D.
4:58 – 5:06 p.m. ET

On-Demand Sessions

Session QU.RFO.16
Neighborhood perception is associated with physical activity and nutrition self-efficacy among African Americans: The Washington, DC cardiovascular health and needs Assessment
Foster Oseh Baah, Ph.D., Tiffany Powell-Wiley, M.D.
8:00 a.m. – 5:30 p.m. ET

Session PH.AOS.399
V180 - Plasma cell-free DNA predicts survival and maps tissue-specific sources of injury in pulmonary arterial hypertension
Michael Solomon, M.D., Mehdi Pirooznia, M.D., Ph.D., Sean Agbor-Enoh M.D., Ph.D., Manreet Kanwar, M.D.
8:00 a.m. – 5:30 p.m. ET

Session AT.AOS.378
280 - Regulation of blood pressure by smooth muscle TRPV4 channels under normal and hypertensive conditions
Yen-Lin Chen, Ph.D.
8:00 a.m. – 5:30 p.m. ET

Session EP.CVS.389
NHLBI’s vision for preserving cardiovascular health across the life course
David Goff, M.D., Ph.D.
8:00 a.m. – 5:30 p.m. ET

Session EP.AOS.424
Pursuing a heart-healthy planet
David Goff, M.D., Ph.D.
8:00 a.m. – 5:30 p.m. ET

Session LF.EC.55
Meet the experts: Leaders of NHLBI and NINDS-funded cohorts
NHLBI: ARIC, CARDIA, CHS, FHS, HCHS/SOL,JHS, nuMoM2b, RURAL; NCI: HPFS; NINDS/NIA: REGARDS
8:00 a.m. – 5:30 p.m. ET

Session AT.CVS.245
Single-cell RNA sequencing reveals heterogeneity of vascular cells in early stage murine abdominal aortic aneurysm
Bo Liu, Ph.D.
8:00 a.m. – 5:30 p.m. ET

Session CM.RFO.22
RF66 - Multidimensional sleep health is associated with cardiometabolic health in a nationally representative sample of US adults
Nour Makarem, Ph.D.
8:00 a.m. – 5:30 p.m. ET

Session HF.CVS.279
How funding sponsors are supporting new methods of achieving equity
George Mensah, M.D.
8:00 a.m. – 5:30 p.m. ET

Session IM.CVS.392
Whither disparities in hypertrophy/heart failure
George Mensah, M.D.
8:00 a.m. – 5:30 p.m. ET

Session LF.CVS.250
Role of the community in cardiometabolic care - impact of infrastructure and communities on health
Tiffany Powell-Wiley, M.D.
8:00 a.m. – 5:30 p.m. ET

Session EA.AOS.456
195 - Race-specific models to predict in-hospital mortality in patients with heart failure using machine learning: The American Heart Association get with the guidelines registry
Tiffany Powell-Wiley, M.D., David Kao, M.D.
8:00 a.m. – 5:30 p.m. ET

Session EP.RFO.15
RF41 - Racial and gender differences in lifetime healthcare costs across cardiovascular risk factors
Tiffany Powell-Wiley, M.D., Rohan Khera, M.D.
8:00 a.m. – 5:30 p.m. ET

Session GE.APS.1221: P1391
Epigenetic risk score capturing alcohol consumption is not associated with cardiac structure and function: The Framingham Heart Study
Helena Bui, Amena Keshawarz, Ph.D., Vasan Ramachandran, M.D., Daniel Levy, M.D.
8:00 a.m. – 5:30 p.m. ET

Session PH.CVS.329
Putting PVDOMICS into practice
Moderator: Lei Xiao, , M.D., Ph.D.
8:00 a.m. – 5:00 p.m. ET

Session VA.RFO.20
Thrombosis, antithrombotics, and antiplatelets
Moderator: Yogendra Kanthi, M.D.
8:00 a.m. – 5:00 p.m. ET

Session CA.ME.486 - Organ on Demand: 3D Printing for CVD
In situ Expansion, Differentiation, and Electromechanical Coupling of Human Cardiac Muscle in a 3D Bioprinted, Chambered Organoid 
Brenda Ogle, Ph.D.
5:00 – 5:15 p.m. ET

Session MP.AOS.450
V17 - Plasma Proteomic Profiling of Endurance Exercise Identified Changes in Extracellular Matrix Biologly Associated with Adaptations in Maximal Oxygen Uptake
Prashant Rao, M.D.
8:00 a.m. – 5:30 p.m. ET

Poster Sessions

Session DD.APS.01: P773
Novel fumarate prodrug rescues cardiomyopathy and motor function in Friedreich's Ataxia 
Elena Dedkova, Ph.D.
8:00 a.m. – 5:30 p.m. ET

Session AT.APS.02: P121
Resolution of inflammation via Rvd1/fpr2 signaling in abdominal aortic aneurysms
Amanda Filiberto, M.D. 
8:00 a.m. – 5:30 p.m. ET

Session AT.APS.02: P114
Isolated liver perfusion and electron microscopy reveal defect in Vldl lipidation associated with inactivation of Tm6sf2
Helen Hobbs, M.D.
8:00 a.m. – 5:30 p.m. ET

Session AT.APS.01: P105
Plasma apolipoprotein C3 is negatively associated with high lipoprotein(a) plasma levels in healthy volunteers
Anastasiya Matveyenko, Gissette Reyes-Soffer, M.D.
11:00 a.m. – 12:00 p.m. ET

Session AT.APS.01
Total lipoprotein lipase deficiency does not impact atherosclerosis development in low density lipoprotein receptor deficient mice
Debapriya Basu, Ira Goldberg, M.D.
11:00 a.m. – 12:00 p.m. ET

Session SA.APS.02: P2881
Insulin-like growth factor binding protein 2 is a novel marker of early smooth muscle cell phenotype modulation in thoracic aortic aneurysm
Albert J. Pedroza, M.D.
11:00 a.m. – 12:00 p.m. ET


Sunday, November 14, 2021


Live Sessions

Session ReSS.AOS.03
RO15 - A randomized trial of a physiologic-directed point-of-care training and debriefing intervention for cardiac arrest
Robert Sutton, M.D.
8:24 – 8:36 a.m. ET

LATE-BREAKING Session LBS.03
Posterior left pericardiotomy reduces postoperative atrial fibrillation after cardiac surgery
Mario Gaudino, M.D.
8:28 – 8:38 a.m. ET

Session AT.ME.238
Paradigm shift of understanding human atherosclerosis: Single-cell immune landscape
Chiara Giannarelli, M.D., Ph.D.
5:00 – 5:10 p.m. ET

Poster Sessions

Session AT.APS.03: P130
Endothelial pannexin1-TRPV4 signaling regulates pulmonary arterial pressure
Rupak Mukherjee Ph.D., Jeffrey Jones, Ph.D., Jean Ruddy, M.D.
11:00 a.m. – 12:00 p.m. ET

Session AT.APS.03: P130
Endothelial pannexin1-TRPV4 signaling regulates pulmonary arterial pressure
Zdravka Daneva, Ph.D.
11:00 a.m. – 12:00 p.m. ET

Session CA.APS.05
New horizons in cardioprotection
Elizabeth Murphy, Ph.D.
11:00 a.m. – 12:00 p.m. ET

Session CH.APS.07: P599
Establishing normal pediatric aortic valve cusp effective height utilizing the Pediatric Heart Network normal echo Z score project echocardiograms
Ben Goot, M.D.
11:00 a.m. – 12:00 p.m. ET

Session EP.APS.11: P1162
Are CAC scores less valuable for patients of low socioeconomic status? A Dallas Heart Study analysis
Tiffany Powell-Wiley, M.D.
11:00 a.m. – 12:00 p.m. ET

Session SA.APS.05: P2905
Health status outcomes of percutaneous coronary intervention and coronary artery bypass grating in stable coronary disease: secondary analysis of the ISCHEMIA Trial
Chetan Huded, M.D.
3:30 – 4:30 p.m. ET

Session GE.APS.04: P1320
Identification of allele-specific gene expression in association with blood pressure
Amena Keshawarz, Ph.D.
3:30 – 4:30 p.m. ET


Monday, November 15, 2021


Live Sessions

Session CE.EC.405
Customizing your career: an open discussion with distinguished panelists
Moderator: Renee Wong, Ph.D.
11:00 a.m. – 12:00 p.m. ET

LATE-BREAKING Session LBS.07
P2y12 inhibitors in noncritically ill hospitalized patients with COVID-19
Judith Hochman, M.D., Jeff Berger, M.D.
11:11 – 11:19 a.m. ET

Poster Sessions

Session QCOR.APS.04: P2664
Association of medical non-adherence to health status outcomes in the ISCHEMIA Trial
Raul Garcia, Ph.D.
8:00 a.m. – 5:00 p.m. ET

Session AC.APS.05: P51
Heterogeneity of benefit on quality of life with an invasive versus conservative strategy for chronic coronary disease. Results from the ISCHEMIA Trial
Suzanne Arnold
11:00 a.m. – 12:00 p.m. ET

Session CH.APS.12: P650
Global longitudinal strain and longitudinal early diastolic strain rate may identify those Williams syndrome patients at risk of cardiomyopathy development
Marie Carillo, M.D.
1:30 – 2:30 p.m. ET